Diaceutics PLC (FRA:7DC)

Market Cap	143.01M +11.6%
Revenue (ttm)	40.13M +31.8%
Net Income	-1.77M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	177.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	249
Open	1.610
Previous Close	1.610
Day's Range	1.610 - 1.610
52-Week Range	1.200 - 1.860
Beta	n/a
RSI	47.61
Earnings Date	May 27, 2026

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using...

• Industry: Commercial Physical and Biological Research
• Founded: 2005
• Employees: 213
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7DC

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.

Financial numbers in GBP